StonvexLoading…
StonvexStonvexStonvexCore line items from AMTB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $597.43M | $595.59M | $548.58M | $338.78M |
Operating Income | $66.14M | $-24.08M | $41.33M | $78.58M |
Net Income | $52.42M | $-15.75M | $32.49M | $63.31M |
EPS (Diluted) | $1.26 | $-0.44 | $0.96 | $1.85 |
Total Assets | $9.78B | $9.90B | $9.72B | $9.13B |
Total Liabilities | $8.84B | $9.01B | $8.98B | $8.42B |
Cash & Equivalents | $470.15M | $590.36M | $321.87M | $290.60M |
Free Cash Flow OCF − CapEx | $129.24M | $74.79M | $15.79M | $-59.79M |
Shares Outstanding | 41.73M | 35.76M | 33.68M | 33.82M |